Vaccination Rates
|
Family Med Clinics (A)
|
Family Med Clinics (B)
|
Internal Med Clinics (C)
|
---|
Baseline
|
Interim
|
Follow-up
|
p-value
|
Baseline
|
Interim
|
Follow-up
|
p-value
|
Baseline
|
Interim
|
Follow-up
|
p-value
|
---|
High risk adults aged 19–64 years
|
PCV13 eligible
|
691
|
961
|
994
| |
732
|
982
|
1088
| |
1030
|
1369
|
1308
| |
Vaccinated (n)
|
14
|
117
|
199
|
<.0001
|
17
|
135
|
261
|
<.0001
|
30
|
247
|
363
|
<.0001
|
Vaccinated (%)
|
2.03
|
12.17
|
20.02
| |
2.32
|
13.75
|
23.99
| |
2.91
|
18.04
|
27.75
| |
PPSV23 eligible
|
734
|
1000
|
1048
| |
785
|
1024
|
1139
| |
1125
|
1395
|
1393
| |
Vaccinated (n)
|
146
|
278
|
302
|
<.0001
|
182
|
260
|
351
|
0.0004
|
317
|
427
|
491
|
0.0005
|
Vaccinated (%)
|
19.89
|
27.80
|
28.82
| |
23.18
|
25.39
|
30.82
| |
28.18
|
30.61
|
35.25
| |
Immunocompetent adults aged 65+
|
PCV13 eligible
| |
2429
|
2807
| | |
2966
|
3724
| | |
5403
|
5530
|
<.0001
|
Vaccinated (n)
|
NA
|
997
|
1677
| | |
971
|
2177
| | |
2842
|
3778
| |
Vaccinated (%)
|
NA
|
41.05
|
59.74
| | |
32.74
|
58.46
| | |
52.60
|
68.32
| |
PPSV23 eligible
|
2162
|
1796
|
2167
| |
2519
|
2360
|
2683
| |
4799
|
3519
|
4687
| |
Vaccinated (n)
|
1368
|
981
|
1219
|
<.0001
|
1356
|
1196
|
1301
|
0.001
|
3253
|
1999
|
3017
|
<.0001
|
Vaccinated (%)
|
63.27
|
54.62
|
56.25
| |
53.83
|
50.68
|
48.49
| |
67.78
|
56.81
|
64.37
| |
Immunocompromised Adults Aged 65+
|
PCV13 eligible
|
453
|
578
|
600
| |
452
|
619
|
684
| |
1374
|
1878
|
1777
| |
Vaccinated (n)
|
2
|
248
|
416
|
<.0001
|
4
|
239
|
440
|
<.0001
|
9
|
1091
|
1323
|
<.0001
|
Vaccinated (%)
|
0.44
|
42.91
|
69.33
| |
0.88
|
38.61
|
64.33
| |
0.66
|
58.09
|
74.45
| |
PPSV23 eligible
|
516
|
589
|
637
| |
512
|
642
|
742
| |
1549
|
1894
|
1907
| |
Vaccinated (n)
|
369
|
391
|
434
|
0.180
|
327
|
416
|
492
|
0.6559
|
1144
|
1303
|
1397
|
0.0011
|
Vaccinated (%)
|
71.51
|
66.38
|
68.13
| |
63.87
|
64.8
|
66.31
| |
73.85
|
68.8
|
73.26
| |
- Bold text indicates statistical significance